Enalapril-induced toxic pustuloderma

Authors: FERGUSON, J.E.¹; CHALMERS, R.J.G.¹

Source: Clinical & Experimental Dermatology, Volume 21, Number 1, January 1996 , pp. 54-55(2)

Publisher: Blackwell Publishing

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Enalapril is widely prescribed for hypertension and cardiac failure. Rashes are an uncommon side-effect, occurring in approximately 1.4% of patients, and in approximately 0.4% of patients the rash is sufficient to require discontinuation of enalapril. (Merck Sharp and Dohme, pers. comm.) We report a case of toxic pustuloderma related to enalapril therapy for congestive cardiac failure. To our knowledge enalapril-induced toxic pustuloderma has not been previously reported.

Document Type: Research article

DOI: 10.1046/j.1365-2230.1996.d01-159.x

Affiliations: 1: Salford Royal Hospitals NHS Trust, University Department of Dermatology, Chapel Street, Salford, Lancs, M60 9EP, UK

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax Refund Policy